CS
BCTXW

Clear Street’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

Clear Street’s Portfolio BCTXW Stock Details BCTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$10 – 685
2025
Q1 		$10 Buy
+100
New +$14 ﹤0.01% 560

Other funds holding BCTXW

RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clear Street's BCTXW Position: Q2 2025 in Review

Clear Street sold out of BriaCell Therapeutics Corp Warrant (BCTXW) in Q2 2025, closing a stake of 100 shares — an estimated $10 sold.

Clear Street first reported a position in BCTXW in Q1 2025 and held it in 1 quarter. The position peaked at $10 in Q1 2025. 6 funds tracked by Wall St. Rank hold BCTXW as of Q2 2025.

  • Clear Street reported no remaining BriaCell Therapeutics Corp Warrant position as of Q2 2025 after selling out during the quarter.
  • Clear Street sold 100 BriaCell Therapeutics Corp Warrant shares in Q2 2025, an estimated $10.
  • Clear Street first reported a position in BriaCell Therapeutics Corp Warrant in Q1 2025 and held it in 1 quarter.
  • Clear Street's BriaCell Therapeutics Corp Warrant position peaked at $10 in Q1 2025.
  • 6 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q2 2025.

Based on Clear Street's 13F filing for Q2 2025, filed 13 Aug 2025.